Kirkman Matthew Anthony, Korsten Alex, Leonhardt Miriam, Dimitriadis Konstantin, De Coo Ireneaus F, Klopstock Thomas, Griffiths Philip G, Hudson Gavin, Chinnery Patrick F, Yu-Wai-Man Patrick
Mitochondrial Research Group, The Medical School, Newcastle University, Newcastle-upon-Tyne, United Kingdom.
Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3112-5. doi: 10.1167/iovs.08-3166. Epub 2009 Feb 28.
Leber hereditary optic neuropathy (LHON) is an inherited mitochondrial optic neuropathy characterized by bilateral, severe loss of central vision. In this study, the first formal assessment was conducted of visual disability in affected and unaffected individuals from molecularly confirmed LHON pedigrees.
Four hundred two LHON carriers--196 affected and 206 unaffected--from 125 genealogically distinct pedigrees were prospectively interviewed using the well-validated visual function index (VF-14) questionnaire: m.3460G>A (n = 71), m.11778G>A (n = 270), and m.14484T>C (n = 61).
The mean age of onset of visual loss was 27.9 years (SD, 14.9) and mean disease duration was 15.5 years (SD, 15.4), with 74.5% of the affected subjects being men. The mean VF-14 score was 25.1 (SD, 20.8) in the affected patients, compared with 97.3 (SD, 7.1) in the unaffected carriers. Within the affected group, VF-14 score did not worsen with increasing disease duration and individuals with the m.14484T>C mutation had higher VF-14 scores compared with those in the m.3460G>A and m.11778G>A groups. Reading small print and reading a newspaper or book were the two VF-14 items that presented the greatest difficulty.
LHON has a severe negative impact on quality of life and has the worst VF-14 score when compared with other previously studied ophthalmic disorders. However, affected LHON carriers can be reassured that their level of visual impairment is unlikely to progress with time. The VF-14 questionnaire will be a useful tool for assessing the natural history of LHON and measuring outcome in future treatment trials.
Leber遗传性视神经病变(LHON)是一种遗传性线粒体视神经病变,其特征为双侧严重的中心视力丧失。在本研究中,首次对分子确诊的LHON家系中受影响和未受影响个体的视觉残疾情况进行了正式评估。
使用经过充分验证的视觉功能指数(VF-14)问卷,对来自125个谱系不同的家系中的402名LHON携带者进行了前瞻性访谈,其中196名受影响,206名未受影响:m.3460G>A(n = 71)、m.11778G>A(n = 270)和m.14484T>C(n = 61)。
视力丧失的平均发病年龄为27.9岁(标准差,14.9),平均病程为15.5年(标准差,15.4),74.5%的受影响受试者为男性。受影响患者的平均VF-14评分为25.1(标准差,20.8),而未受影响携带者的评分为97.3(标准差,7.1)。在受影响组中,VF-14评分并未随病程延长而恶化,与m.3460G>A和m.11778G>A组相比,携带m.14484T>C突变的个体VF-14评分更高。阅读小号印刷字体以及阅读报纸或书籍是VF-14问卷中最难完成的两项。
与其他先前研究的眼科疾病相比,LHON对生活质量有严重负面影响,且VF-14评分最差。然而,受影响的LHON携带者可以放心,他们的视力损害程度不太可能随时间进展。VF-14问卷将成为评估LHON自然史以及衡量未来治疗试验结果的有用工具。